Boston Scientific IDE Violations Related To SCORES Trial Cited By FDA
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific's failure to ensure investigator compliance at certain centers involved in the SCORES clinical trial for the Radius self-expanding coronary stent is highlighted in a July 23 FDA warning letter to the firm's Scimed Life Sciences division citing the firm for investigational device exemption violations.